Microtubule Inhibitors
Learn MorePoly (ADP-ribose) polymerase (PARP) inhibitors are a novel class of pharmaceutical drugs that target the PARP enzymes involved in DNA repair pathways By inhibiting PARP these drugs disrupt the repair mechanisms in cancer cells leading to their selective death This makes PARP inhibitors a promising therapeutic option for the treatment of various cancers particularly those associated with BRCA mutations Our company offers a comprehensive range of highly effective PARP inhibitors that have shown significant clinical benefit in the fight against cancer
Catalog Number | Chemical Name | CAS # | Price |
---|---|---|---|
BC-0019 | Phenformin hydrochloride | 834-28-6 | Online Inquiry |
EI-0026 | 1,5-Isoquinolinediol | 5154-02-9 | Online Inquiry |
EI-0059 | 4-Hydroxyquinazoline | 491-36-1 | Online Inquiry |
EI-0088 | A-966492 | 934162-61-5 | Online Inquiry |
EI-0103 | ABT-888 | 912445-05-7 | Online Inquiry |
EI-0133 | AG-014699 phosphate | 459868-92-9 | Online Inquiry |
EI-0136 | AG-14361 | 328543-09-5 | Online Inquiry |
EI-0284 | AZD-2461 | 1174043-16-3 | Online Inquiry |
EI-0411 | BMN-673 | 1207456-01-6 | Online Inquiry |
EI-0765 | DPQ | 129075-73-6 | Online Inquiry |
EI-0768 | DR2313 | 284028-90-6 | Online Inquiry |
EI-1216 | Iniparib | 160003-66-7 | Online Inquiry |
EI-1218 | INO-1001 | 3544-24-9 | Online Inquiry |
EI-1429 | ME-0328 | 1445251-22-8 | Online Inquiry |
EI-1471 | MK-4827 | 1038915-60-4 | Online Inquiry |
Poly (ADP-ribose) Polymerase (PARP) inhibitors have a wide range of applications in both research and medicine In the field of research PARP inhibitors are commonly used to study DNA repair mechanisms and the role of PARP enzymes in cellular processes By inhibiting PARP researchers can gain valuable insights into the underlying mechanisms of DNA damage and repair which can contribute to the development of new therapies for cancer and other diseases
In medicine PARP inhibitors are primarily used to treat cancers that have a specific DNA repair defect known as homologous recombination deficiency (HRD) These inhibitors work by blocking the activity of PARP enzymes which are necessary for the repair of single-strand DNA breaks In HRD cancers blocking PARP leads to the accumulation of DNA damage ultimately leading to cell death This targeted approach has shown promise in the treatment of breast ovarian and other types of cancer and is shaping the future of precision medicine
PARP inhibitors also have potential applications beyond cancer treatment They are being investigated for their role in neurodegenerative diseases such as Alzheimer's and Parkinson's as well as in cardiovascular diseases Additionally PARP inhibitors are being explored for their potential to enhance the effectiveness of radiation therapy or chemotherapy in cancer treatment
Overall PARP inhibitors are a versatile tool with significant implications for both research and medicine Their ability to target specific DNA repair pathways has opened up new avenues of treatment and research offering hope for improved outcomes and better understanding of various diseases
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.